Crossmark

Lower prevalence of elevated liver stiffness measurements in people with type 2 diabetes taking sodium-glucose co-transporter 2 inhibitors or glucagon-like peptide-1 receptor agonists

Crossref DOI link: https://doi.org/10.1016/j.aohep.2023.101142

Published Print: 2023-11

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Gracen, Lucy https://orcid.org/0000-0002-2154-5830
Muthukumara, Withma https://orcid.org/0009-0005-5119-7303
Aikebuse, Melanie

Russell, Anthony https://orcid.org/0000-0001-7886-8844
O'Beirne, James

Irvine, Katharine M.

Williams, Suzanne

Puri, Gaurav

Valery, Patricia C.

Hayward, Kelly L.

Powell, Elizabeth E.
Funding

Funding for this research was provided by:

Metro South Health Service District

Health Innovation, Investment and Research Office
License Information

Text and Data Mining valid from 2023-11-01

Text and Data Mining valid from 2023-11-01

Version of Record valid from 2023-07-14
More Information

This article is maintained by: Elsevier

Article Title: Lower prevalence of elevated liver stiffness measurements in people with type 2 diabetes taking sodium-glucose co-transporter 2 inhibitors or glucagon-like peptide-1 receptor agonists

Journal Title: Annals of Hepatology

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.aohep.2023.101142

Content Type: article

Copyright: Crown Copyright © 2023 Published by Elsevier España, S.L.U. on behalf of Fundación Clínica Médica Sur, A.C.

Document is current

Any future updates will be listed below